Literature DB >> 1460143

Evaluation of a nisin-based germicidal formulation on teat skin of live cows.

P M Sears1, B S Smith, W K Stewart, R N Gonzalez, S D Rubino, S A Gusik, E S Kulisek, S J Projan, P Blackburn.   

Abstract

A purified preparation of the nontoxic antimicrobial peptide, nisin (AMBICIN N), was used in the formulation of a germicidal sanitizer suitable for use on cow teats. The germicidal activity of the formulation against mastitis pathogens was measured on teat skin of live cows. The nisin-based formulation gave a mean log reduction of 3.90 against Staphylococcus aureus and 4.22 log reduction against Escherichia coli after exposure for 1 min to the germicide. This activity was comparable with that exhibited by a 1% iodophor teat dip but was significantly greater than that exhibited by the .1 and .5% iodophors and by the .5% chlorhexidine digluconate teat dips. The nisin-based formulation showed little or no potential for skin irritation after multiple application to skin, but iodophor and chlorhexidine digluconate teat dips showed significant potential for skin irritation in comparable studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460143     DOI: 10.3168/jds.S0022-0302(92)78083-7

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  16 in total

1.  The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.

Authors:  Lorraine A Draper; John R Tagg; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Bacteriocins of Non-aureus Staphylococci Isolated from Bovine Milk.

Authors:  Domonique A Carson; Herman W Barkema; Sohail Naushad; Jeroen De Buck
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

3.  Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147.

Authors:  Fiona Crispie; James Flynn; R Paul Ross; Colin Hill; William J Meaney
Journal:  Ir Vet J       Date:  2004-11-01       Impact factor: 2.146

4.  Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains.

Authors:  Antonio Maldonado-Barragán; Nivia Cárdenas; Beatriz Martínez; José Luis Ruiz-Barba; José F Fernández-Garayzábal; Juan M Rodríguez; Alicia Gibello
Journal:  Appl Environ Microbiol       Date:  2013-05-10       Impact factor: 4.792

5.  Purification and partial characterization of a novel antibacterial agent (Bac1829) Produced by Staphylococcus aureus KSI1829.

Authors:  S S Crupper; J J Iandolo
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

6.  Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.

Authors:  Junqiang Wu; Songhua Hu; Liting Cao
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

7.  Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.

Authors:  Des Field; Lisa Quigley; Paula M O'Connor; Mary C Rea; Karen Daly; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Microb Biotechnol       Date:  2010-07       Impact factor: 5.813

8.  Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.

Authors:  Evelyn M Molloy; Des Field; Paula M O' Connor; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

9.  Mode of action and In Vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin.

Authors:  Renee Pieterse; Svetoslav D Todorov; Dicks Leon M T
Journal:  Braz J Microbiol       Date:  2010-03-01       Impact factor: 2.476

10.  Bacteriocins - exploring alternatives to antibiotics in mastitis treatment.

Authors:  Reneé Pieterse; Svetoslav D Todorov
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.